🚨🚨We are pleased to publish the next output via the HoLISTIC consortium (Hodgkin Lymphoma International STudy for Individual Care: hodgkinconsortium.com): The E-HIPI (Early-Stage Hodgkin International Prognostic Index) prediction model for early-stage Hodgkin lymphoma. 1/9🧵

Kickoff of MPN Ad&Ed Int'l #MPN patient meeting in #CLT, the start of #MPNWorkshop of Carolinas! Atrium Health Wake Forest Baptist Comprehensive Cancer Center Levine Cancer Naveen Pemmaraju, MD Elf Lab 🇺🇦🏳️‍🌈🏳️‍⚧️⚧️👊🏾👊🏽🌈🟧 Brandi Reeves Lindsay Rein Tania Jain Wake Forest University School of Medicine Duke Cancer UNC Lineberger MUSC Hollings Cancer Center

Congratulations, Zeynep Irem Ozay, MD and Neeraj Agarwal, MD, FASCO. Great work, meaningful information‼️🌟

Co-organizers Ruben A. Mesa, MD & Naveen Pemmaraju, MD kicking off the MPN Workshop of the Carolinas! #mpnsm

We loved our chat with VJHemOnc ! Thrilled by your help sharing the advances in MPNs at our #MPNworkshop of the Carolinas! Atrium Health Levine Cancer Wake Forest University School of Medicine

👉👉👉 Phenomenal Day 1 of our #MPNWorkshop25 led by Ruben A. Mesa, MD & Naveen Pemmaraju, MD !! So thankful 🙏 to all of our team & colleagues for making this making meeting happen! #MPNSM | PedsHemeDoc Sanam Loghavi, MD صنم لغوی 🔬🧬 Ami Patel, MD Andrew Kuykendall MD Prithviraj Bose Andrew Dunbar Aaron Gerds MD, MS Stephen Oh |

Beyond proud of this incredible, dedicated, brilliant physician/chief fellow/colleague 🤩 Way to go Dena Rhinehart, MD Johns Hopkins Hematology and Oncology Fellowship Johns Hopkins Kimmel Cancer Center

We are recruiting! Feel free to contact me if you are interested in this key leadership position on our team! It is a great opportunity to make an impact at a leading cancer center and health system linkedin.com/jobs/view/4230…

🚨 NEW PUBLICATION ALERT!!! 🚨 Consensus Statement: Clinical strategies for lung cancer management: Recommendations from the 2024 Bridging the Gaps Lung Cancer Consensus Conference. 🔗 acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… 👇 Quick thread with key highlights 🧵

.MD Anderson Cancer Center research teams are using mathematical modeling to tackle some of cancer’s toughest questions, including treatment timing and tumor growth. Learn more about how our experts are pursuing breakthroughs in cancer care: bit.ly/45aeHqX #EndCancer

An excellent session for our patients and their caregivers to empower them as they navigate their disease journey! I will be presenting on extranodal and 🧠🧠 lymphoma MD Anderson Cancer Center Lymphoma Hub LymphomaAction Women in Lymphoma - wilLymphoma Research Foundation.org.au Hematology & Oncology Women Physicians Group—HOWPG @lymphoma

🌍✨ Global Derm Oncology Leader Dr. Shamir Geller and the Memorial Sloan Kettering Cancer Center team present new insights on mogamulizumab in mycosis fungoides (MF) & Sézary syndrome (SS). 📊 In a retrospective study of 56 patients: 43% achieved skin response (median 2.3 mo)

If you told me a few years ago I’d be invited to speak at IASLC #WCLC25, not just on research, but on how social media fuels patient education & advocacy, I’d have said you were CRAZY. Lean into what you love. Even if it’s not the norm. Especially when it helps patients 🤍

Honored to present my final project results today at the IASLC Academy. Grateful to be part of this inspiring 2025 cohort. Huge THANKS to the mentors and IASLC for the guidance and opportunity! Dr. Luis E. Raez Christian Rolfo Rami Manochakian MD, FASCO Cancer Education Dr. Amy C. Moore Laura Alder, MD Jair Bar

👉👉👉Fabulous work by Aditi Pemmaraju 📣.Aditi Pemmaraju, J.D. ➡️ Real Estate 🏡 focused on Physicians & Health Professionals & the entire process of Physician Relocation | 🙌 homesforhealers.net compass.com/agents/aditi-p… Ruben A. Mesa, MD Anirban Maitra Sanam Loghavi, MD صنم لغوی 🔬🧬 Muzaffar Qazilbash

We’re working to bridge the gaps in research, care, and experience for young patients #LungCancer #YoungLungCancer #OncologyResearch #FlorezLab

Excited to share our new paper focusing on relapse mechanisms and post relapse outcomes following frontline FLT3i therapy in FLT3-AML, stratified by type of induction regimen and allogeneic SCT. #leusm #MedTwitter Sanam Loghavi, MD صنم لغوی 🔬🧬 Naval Daver, M.D.

Check out our publication about the management of Amivantamab adverse events! The Oncologist #FlorezLab